RECRUITING
I'm interested ...!!
The Nanowear Wearable Covid-19 Observational and Analysis Trend
The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.
Conditions:
🦠 Covid19
🗓️ Study Start (Actual) 15 September 2020
🗓️ Primary Completion (Estimated) 31 December 2023
✅ Study Completion (Estimated) 31 December 2023
👥 Enrollment (Estimated) 100
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Hackensack, New Jersey, United States
📍 Brooklyn, New York, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Subject has provided informed consent
    • * Male or female over the age of 18 years
    • * The patient is currently hospitalized with a primary diagnosis of Covid-19

    Exclusion Criteria:

    • * Subject is unwilling or unable to wear the vest during hospitalization.
    • * Subjects who are pregnant.
    • * Subject is intubated or admitted to ICU
    • * Subject has an implantable cardiac device (i.e pacemaker or internal cardioverter defibrillator)
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 19 January 2021
  • First Submitted that Met QC Criteria 19 January 2021
  • First Posted 20 January 2021

Study Record Updates

  • Last Update Submitted that Met QC Criteria 7 November 2023
  • Last Update Posted 8 November 2023
  • Last Verified November 2023
I'm interested ...!!